KLOW

Product Overview

KLOW Blend

BPC-157 + TB-500 + KPV + GHK-Cu is a quad-pathway peptide complex formulated for scientific research into tissue regeneration, inflammation modulation, and systemic recovery. This advanced combination integrates four research-backed peptides—BPC-157, TB-500, KPV, and GHK-Cu—each targeting a unique aspect of healing, repair, and restoration. Together, they provide a comprehensive research model for studying multi-system recovery, immune regulation, and cellular rejuvenation across muscular, vascular, and epithelial systems.

• BPC-157 (Body Protection Compound-157) is a naturally occurring peptide fragment studied for its ability to stimulate fibroblast activity, promote angiogenesis, and enhance tendon, muscle, and gut repair. Through interaction with nitric oxide and growth factor pathways, it has become a key model for research into inflammation control, connective-tissue healing, and cellular resilience following injury or stress.

• TB-500 (Thymosin Beta-4 fragment) supports this regenerative action by influencing actin polymerization, a process essential for cell migration and tissue remodeling. Researchers study TB-500 for its ability to promote angiogenesis, increase blood flow, and enhance microvascular repair, making it a critical component in wound-healing and musculoskeletal recovery studies.

• KPV (Lys-Pro-Val), a tripeptide derived from $\alpha$-Melanocyte-Stimulating Hormone ($\alpha$-MSH), has been investigated for its potent anti-inflammatory and immune-modulating effects. It is often studied for its ability to help restore epithelial balance, stabilize gut barrier integrity, and reduce pro-inflammatory cytokine activity, providing valuable insight into systemic inflammation and immune regulation.

• GHK-Cu (Copper Tripeptide-1) adds a rejuvenating dimension to the blend, studied for its role in collagen production, antioxidant activity, and tissue remodeling. By supporting dermal health, cell renewal, and wound repair, GHK-Cu has become a central compound in research exploring skin vitality, anti-aging pathways, and hair follicle regeneration.

When combined in the KLOW Blend, these four peptides deliver a synergistic multi-system model that unites repair, recovery, and rejuvenation into one formula. The blend’s combined activity supports research into collagen synthesis, vascular remodeling, inflammation control, and immune modulation, offering scientists a complete picture of whole-body regeneration. By targeting overlapping pathways—cellular repair (BPC-157), angiogenesis and remodeling (TB-500), inflammation balance (KPV), and collagen renewal (GHK-Cu)—the KLOW Blend represents an advanced model for understanding systemic recovery and tissue optimization. Together, these compounds form a unified research framework for studying connective-tissue health, dermal regeneration, and inflammatory regulation under controlled experimental conditions.

Key Research Benefits

• Studied for its multi-pathway effects on cellular recovery, inflammation reduction, and tissue regeneration

• Supports research into angiogenesis, collagen synthesis, and immune system modulation

• May aid in understanding gut barrier repair, vascular remodeling, and connective-tissue health

• Explored for potential applications in wound healing, skin vitality, and systemic recovery studies

• Provides a comprehensive, synergistic research model for observing cellular rejuvenation and repair

• As a blend, offers a quad-pathway approach to studying immune, vascular, and regenerative processes

Disclaimer: All products, including the KLOW Blend (BPC-157 + TB-500 + KPV + GHK-Cu), are sold for laboratory and research purposes only.

Not for human consumption, medical, or veterinary use.